D7 Extra-Genital Screening: For Those Times When Genital-Based Screening Isn't Enough

Earn CE Credit for viewing the archived recordings of the 2012 STD Conference.

Deadline: April 12, 2014

For details, click Continuing Education Information

Thursday, March 15, 2012: 8:30 AM-10:15 AM
Greenway Ballroom H/I/J

8:30 AM
Oral, Vaginal, and Anal Human Papillomavirus (HPV) Infection in HIV+ Women
Ping Du, MD, PhD, Department of Medicine, College of Medicine, Pennsylvania State University, Hershey, PA, John Zurlo, MD, Department of Medicine, Pennsylvania State University, Hershey, PA, Eugene Lengerich, VMD, MS, Department of Public Health Sciences, Pennsylvania State University, Hershey, Craig Meyers, PhD, Department of Microbiology and Immunology, Pennsylvania State University, Hershey, Andrew Read, PhD, Department of Biology and Entomology, Pennsylvania State University, University Park, PA and Neil Christensen, PhD, Department of Pathology, Pennsylvania State University College of Medicine, Hershey
8:42 AM
Synergism: AIDS Service Organization and State Health Department Link Resources to Meet STD Screening and Treatment Needs of Men Who Have Sex with Men (MSM)
David Ponsart, CPC, HIV Prevention Program, ACCESS, Dearborn, MI, Amy Peterson, MPH, STD Program, Michigan Department of Community Health, Detroit, MI and Kathryn Macomber, MPH, Bureau of Epidemiology, Michigan Department of Community Health, Lansing, MI
8:54 AM
Beyond the Guidelines: Clinic-Based Screening for Pharyngeal Chlamydia Trachomatis
Anita Radix, MD, MPH, Gal Mayer, MD, Susan Weiss, NP, Rona Vail, MD, Victor Inada, MD, MA, Ethan Fusaris, BS, MPH(c) and Erin Connolly, BA, Callen-Lorde Community Health Center, New York, NY
9:06 AM
Introduction of Extra-Genital Self-Obtained Nucleic Acid Amplification Tests (NAAT) for Gonorrhea and Chlamydial Infection in MSM in An STD Clinic
Lindley Barbee, MD, MPH, Department of Medicine, Division of Allergy and Infectious Disease, University of Washington, Seattle, WA, Julia Dombrowski, MD, MPH, Department of Medicine (UW) and HIV/STD Program (PHSKC), University of Washington and Public Health - Seattle & King County, Seattel, WA, Roxanne Kerani, PhD, HIV/STD Control Program, Public Health - Seattle and King County, Seattle, WA and Matthew R. Golden, MD, MPH, Center for AIDS and STD, Public Health - Seattle & King County STD Clinic and Department of Medicine, University of Washington, Seattle, WA
9:18 AM
Cephalosporin and Azithromycin Susceptibility in Neisseria Gonorrhoeae Isolates by Site of Infection, British Columbia, 2006-2011
Travis Salway Hottes, MSc1, Richard T. Lester, MD, FRCPC1, Linda MN Hoang, MSc, MD, FRCPC2, Rachel McKay, MSc3, Miguel Imperial, MD, FRCPC2, Mark Gilbert, MD, MHSc, FRCPC1, David Patrick, MD, FRCPC, MHSc3, Tom Wong, MD, MPH, FRCPC4, Irene Martin, BSc5 and Gina Ogilvie, MD, MSc, CCFP, FCFP, DrPH(C)1, 1Clinical Prevention Services, British Columbia Centre for Disease Control, Vancouver, BC, Canada, 2Laboratory Services, British Columbia Centre for Disease Control, Vancouver, BC, Canada, 3Communicable Disease Prevention and Control Services, British Columbia Centre for Disease Control, Vancouver, BC, Canada, 4Public Health Agency of Canada, Ottawa, ON, Canada, 5National Microbiology Laboratory, Winnipeg, MB, Canada
See more of: Oral and Poster